Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898430-97-004738
Filing Date
1997-11-10
Accepted
1997-11-10 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBIOTECHNOLOGY VALUE FUND, L.P.BVF INC.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO SCHEDULE 13D SC 13D/A 16768
2 AGREEMENT REGARDING JOINT FILING EX-99.A 1348
3 STOCK TRANSACTIONS BY REPORTING PERSONS EX-99.B 7850
  Complete submission text file 0000898430-97-004738.txt   28281
Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043 4154281550
MICROCIDE PHARMACEUTICALS INC (Subject) CIK: 0001010915 (see all company filings)

EIN.: 943186021 | State of Incorp.: CA
Type: SC 13D/A | Act: 34 | File No.: 005-47911 | Film No.: 97712039
SIC: 2834 Pharmaceutical Preparations